期刊文献+

对非甾体消炎药延缓强直性脊柱炎结构破坏的再认识 被引量:7

原文传递
导出
摘要 强直性脊柱炎(AS)是一种主要累及脊柱和骶髂关节的慢性进行性炎性疾病,骶髂关节、脊柱骨突关节和椎间盘间隙的骨性融合是该病的特征性病理改变。如未能进行正确的治疗与合理的功能锻炼,许多患者在青年时期就会出现脊柱畸形或功能受限,严重影响其生活质量。因此,AS治疗的一个重要目的是防止脊柱结构损伤的进展、延缓或阻止脊柱融合。
作者 朱剑 黄烽
出处 《中华内科杂志》 CAS CSCD 北大核心 2013年第2期153-155,共3页 Chinese Journal of Internal Medicine
  • 相关文献

参考文献14

  • 1朱剑,黄烽.强直性脊柱炎的新骨形成能被阻断吗?[J].中华内科杂志,2011,50(2):89-91. 被引量:5
  • 2邓小虎,黄烽.强直性脊柱炎的目标治疗[J].中华医学杂志,2011,91(11):725-729. 被引量:15
  • 3van der Heijde D, Landew6 R, Einstein S, et al. Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept. Arthritis Rheum,2008,58:1324-1331.
  • 4Wanders A, Heijde Dr, Landew6 R, et al. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum, 2005,52 : 1756-1765.
  • 5Braun J, van den Berg R, Baraliakos X, et al. 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis ,2011,70:896-904.
  • 6Boersma JW. Retardation of ossification of the lumbar vertebral column in ankylosing spondylitis by means of phenylbutazone. Seand J Rheumatol, 1976,5:60-64.
  • 7Poddubnyy D, Rudwaleit M, Haibel H, et al. Effect of non- steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort. Ann Rheum Dis, 2012,71: 1616-1622.
  • 8Bauer DC, Orwoll ES, Fox KM, et al. Aspirin and NSAID use in older women: effect on bone mineral density and fracture risk. Study of Osteoporotic Fractures Research Group. J Bone Miner Res, 1996,11:29-35.
  • 9Richards JB, Joseph L, Schwartzman K, et al. The effect of cyclooxygenase-2 inhibitors on bone mineral density: results from the Canadian Multicentre Osteoporosis Study. Osteoporos Int, 2006,17 : 1410-1419.
  • 10Bonewald LF, Johnson ML. Osteocytes, mechanosensing and Wnt signaling. Bone, 2008,42:606-615.

二级参考文献21

  • 1黄烽,张莉芸,张江林,张奉春,梁东风,邓小虎,郭军华,朱剑,赵伟,李小峰,侯勇.抗肿瘤坏死因子α单克隆抗体治疗强直性脊柱炎的短期临床观察[J].中华内科杂志,2006,45(2):122-126. 被引量:21
  • 2Sieper J,Baraliakos X,Listing J,et al.Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after 2 yrs of treatment with the anti-tumour necrosis factor agent infliximab.Rheumatology (Oxford),2005,44:1525-1530.
  • 3Braun J,Landewé R,Hermann KG,et al.Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab:results of a multicenter,randomized,double-blind,placebo-controlled magnetic resonance imaging study.Arthritis Rheum,2006,54:1646-1652.
  • 4Lambert RG,Salonen D,Rahman P,et al.Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis:a multicenter,randomized,double-blind,placebo-controlled study.Arthritis Rheum,2007,56:4005-4014.
  • 5van der Heijde D,Landewé R,Einstein S,et al.Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept.Arthritis Rheum,2008,58:1324-1331.
  • 6van der Heijde D,Landewé R,Baraliakos X,et al.Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis.Arthritis Rheum,2008,58:3063-3070.
  • 7van der Heijde D,Salonen D,Weissman BN,et al.Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years.Arthritis Res Ther,2009,11:R127.
  • 8Lories RJ,Derese I,de Bari C,et al.Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis.Arthritis Rheum,2007,56:489-497.
  • 9Appel H,Loddenkemper C,Grozdanovic Z,et al.Correlation of histopathological findings and magnetic resonance imaging in the spine of patients with ankylosing spondylitis.Arthritis Res Ther,2006,8:R143.
  • 10CRUICKSHANK B.Lesions of cartilaginous joints in ankylosing spondylitis.J Pathol Bacteriol,1956,71:73-84.

共引文献16

同被引文献62

  • 1郝慧琴,黄烽.ASAS/EULAR推荐的强直性脊柱炎治疗方案[J].中华风湿病学杂志,2006,10(12):763-765. 被引量:13
  • 2张立,欧国荣,孙宇,潘胜发.围手术期使用塞来昔布对腰椎手术患者的镇痛作用[J].中国脊柱脊髓杂志,2007,17(8):619-622. 被引量:24
  • 3Dougados M, B6hier JM, Jolchine I,et al. Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug. Arthritis Rheum, 2001,44 : 180-185.
  • 4Braun J, van den Berg R, Baraliakos X, et al. 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis,2011,70:896-904.
  • 5Benhamou M, Gossec L, Dougados M. Clinical relevance of C-reactive protein in ankylosing spondylitis and evaluation of the NSAIDs/coxibs' treatment effect on C-reactive protein. Rheumatology (Oxford) ,2010,49:536-541.
  • 6Wanders A, Heijde Dv, Landew6 R, et al. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical triM. Arthritis Rheum ,2005,52 : 1756-1765.
  • 7Straube S, Trainer MR, Moore RA, et al. Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use. BMC Gastroenterol,2009,9:41.
  • 8Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults : results of a US consensus panel of experts. Arch Intern Med, 2003,163:2716-2724.
  • 9Dougados M, Simon P, Braun J, et al. ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/ epidemiological studies in axial spondyloarthritis. Ann Rheum Dis,2011,70:249-251.
  • 10] Ramiro S, Radner I-I, van der Heijde DM, et al. Combination therapy for pain management in inflammatory arthritis: a Cochrane systematic review. J Rheumato! Suppl,2012 ,90 :47-55.

引证文献7

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部